DISTINGUISHED FACULTY OF DRUG DISCOVERY CHEMISTRY 2014
James Wells, Ph.D., University of California San Francisco
Brian Albrecht, Ph.D., Constellation Pharmaceuticals
Abdellah Allali-Hassani, Ph.D., University of Toronto
Dean Richard Artis, Ph.D., Elan
Prabhat Arya, Ph.D., DRILS University of Hyderabad Campus
Kate Ashton, Ph.D., Amgen, Inc.
Valerio Berdini, Ph.D., Astex Pharmaceutical
Paul Bonin, Pfizer, Inc.
Rogier C. Buijsman, Ph.D., Netherlands Translational Research Center B.V.
Lars Burgdorf, Ph.D., Merck KGaA
Julio Camarero, Ph.D., University of Southern California
Robert Carlson, Ph.D., Karyopharm Therapeutics
Zaneta Nikolovska-Coleska, Ph.D., University of Michigan
Stuart Conway, Ph.D., University of Oxford
Adrian Culf, Ph.D., Atlantic Cancer Research Institute
Max Cummings, Ph.D., Janssen
Dan Dairaghi, Ph.D., ChemoCentyrx
Helena Danielson, Ph.D., Uppsala University and Beactica
Ben Davis, Ph.D., Vernalis Ltd.
Gerald Denis, Ph.D., Boston University School of Medicine
Kurt Deshayes, Ph.D., Genentech, Inc.
Bruce Dorsey, Ph.D., Teva Pharmaceuticals
José Duca, Ph.D., Novartis Institutes for BioMedical Research, Inc.
Mark Elban, Ph.D., GSK
Istvan Enyedy, Ph.D., Biogen Idec
Daniel A. Erlanson, Ph.D., Carmot Therapeutics, Inc.
Iwan de Esch, Ph.D., VU University Amsterdam
Lee D. Fader, Ph.D., Boehringer Ingelheim Pharmaceuticals, Inc.
Wolfgang Fecke, Ph.D., UCB Pharma
Fleur Ferguson, University of Cambridge
David Fry, Ph.D., The Chemistry Research Solution (TCRS), LLC
Matthew Fuchter, Ph.D., Imperial College London
Maria Gaczynska, Ph.D., University of Texas Health Science Center at San Antonio
Dmitry Genis, Ph.D., ASINEX
Jason E. Gestwicki, Ph.D., University of California at San Francisco
Danielle Guarracino, Ph.D., The College of New Jersey
Vincent Guerlavais, Ph.D., Aileron Therapeutics
Stefan Günther, Ph.D., University of Freiburg
Jan Hoflack, Ph.D., Oncodesign Biotechnology
Rhian Holvey, Ph.D., University of Cambridge
Edward Holson, Ph.D., The Broad Institute of MIT and Harvard
ChiChi Huang, Ph.D., Janssen R&D, LLC
Roderick Hubbard, Ph.D., Vernalis Ltd.
Jian Jin, Ph.D., University of North Carolina at Chapel Hill
Brad Jordan, Ph.D., Amgen
Vsevolod (Seva) Katritch, Ph.D., The Scripps Research Institute
Aleksey Kazantsev, Ph.D., Harvard Medical School and Massachusetts General Hospital
Roman Kombarov, Ph.D., ASINEX
Isabelle Krimm, Ph.D., University of Lyon, CNRS
Vinod Kurella, Ph.D., Harvard Medical School
Peter Kutchukian, Ph.D., Merck and Co.
Stefan Laufer, Ph.D., University of Tuebingen
Alec Lesback, Ph.D., Janssen Research & Development
Jun Liang, Ph.D., Genentech, Inc.
David Y. Liu, Ph.D., Protagonist Therapeutics, Inc.
Scott Lokey, Ph.D., University of California, Santa Cruz
Karen Maegley, Ph.D., Pfizer, Inc.
Eric Marsault, Ph.D., University of Sherbrooke
Elisabeth Martinez, Ph.D., University of Texas Southwestern Medical Center
Dustin McMinn, Ph.D., Onyx Pharmaceuticals
Pierre-Yves Michellys, Ph.D., The Genomics Institute of the Novartis Research Foundation (GNF)
Christel Menet, Ph.D., Galapagos
Gerhard Mueller, Ph.D., MercaChem BV
Susanne Muller-Knapp, Ph.D., Structural Genomics Consortium (SGC), Oxford
Elmar Nurmemmedov, Ph.D., The Scripps Research Institute
Stuart Onions, Ph.D., Sygnature Discovery Ltd.
Mark Peterson, Ph.D., Tranzyme Pharma, Inc.
Anders Poulsen, Ph.D., A*STAR
Kamal Puri, Ph.D., Gilead Sciences, Inc.
Jun Qi, Ph.D., Dana-Farber Cancer Institute
Rick Roberts, Ph.D., Almirall
Susanta Samajdar, Ph.D., Aurigene Discovery Technologies Limited
Laurent Schio, Ph.D., Oncology, Sanofi
Gloria Serra, Ph.D., Facultad de Química, Universidad de la República
Arun Shukla, Ph.D., Duke University Medical Center
Laura Silvian, Ph.D., Biogen Idec
Nicholas J. Skelton, Ph.D., Genentech, Inc.
Andrew Stamford, Ph.D., Merck
Jan Steyaert, Ph.D., Vrije University Brussels
Terry Stouch, Ph.D., Science for Solutions, LLC
Daqing Sun, Ph.D., Amgen
Takayoshi Suzuki, Ph.D., Kyoto Prefectural University of Medicine
Francisco X. Talamas, Ph.D., formerly Hoffmann-La Roche Inc.
Seng-Lai “Thomas” Tan, Ph.D., EMD Serono Research and Development Institute, Inc.
Steven J. Taylor, Ph.D., Boehringer Ingelheim Pharmaceuticals, Inc.
Nicholas Terrett, Ph.D., Ensemble Therapeutics Corp.
Marc Thommen, Ph.D., Polyphor
Paul R. Thompson, Ph.D., Scripps Florida
Peter Timmerman, Ph.D., Pepscan Therapeutics
Maricel Torrent, Ph.D., AbbVie
Jennifer Venable, Ph.D., Johnson & Johnson Pharmaceutical R&D
Erik Verner, Ph.D., Principia Biopharma
Xiang Wang, Ph.D., University of Colorado at Boulder
Anthony D. William, Ph.D., The Agency for Science, Technology and Research (A*STAR)-ICES
Chris Williams, Ph.D., Chemical Computing Group
Dietmar Wolf, Ph.D., AnalytiCon Discovery, LLC
Damian W. Young, Ph.D., Baylor College of Medicine
Wendy Young, Ph.D., Genentech, Inc.
Edward R. Zartler, Ph.D., Quantum Tessera Consulting
Christoph Zapf, Ph.D., Pfizer Research Labs
Qinghai Zhang, Ph.D., The Scripps Research Institute